Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Insulin aspart 100units/ml solution for injection 10ml vials
0601011A0AAAAAA
|
Insulin aspart | Insulin aspart | Endocrine System | 699 |
|
ActiLymph class 2 (23-32mmHg) below knee closed toe sand
21270000162
|
ActiLymph class 2 (23-32mmHg) below knee closed toe sand | Lymphoedema Garments | Appliances | 698 |
|
Coal tar 2.5% scalp lotion
1309000C0AAAEAE
|
Coal tar (Scalp) | Coal tar | Skin | 698 |
|
Zindaclin 1% gel
1306010F0BCAAAD
|
Zindaclin | Clindamycin phosphate | Skin | 698 |
|
Aquaflush Maxi - Lite System monthly set
21280000146
|
Aquaflush Maxi - Lite System monthly set | Anal Irrigation System | Appliances | 697 |
|
Gentamicin 80mg/2ml solution for injection ampoules
0501040H0AAAAAA
|
Gentamicin sulfate (Systemic) | Gentamicin sulfate | Infections | 697 |
|
Mintreleq XL 300mg tablets
0402010ABBJADAX
|
Mintreleq XL | Quetiapine | Central Nervous System | 697 |
|
Octenilin Wound Gel dressing
20030500025
|
Octenilin Wound Gel dressing | Wound Management & Other Dressings | Dressings | 697 |
|
RespoSorb Silicone Border dressing 12.5cm x 12.5cm square
20033000014
|
RespoSorb Silicone Border dressing 12.5cm x 12.5cm square | Wound Management & Other Dressings | Dressings | 697 |
|
ActiLymph class 2 (23-32mmHg) below knee open toe sand
21270000164
|
ActiLymph class 2 (23-32mmHg) below knee open toe sand | Lymphoedema Garments | Appliances | 696 |
|
Biatain Silicone dressing 17.5cm x 17.5cm
20030900242
|
Biatain Silicone dressing 17.5cm x 17.5cm | Wound Management & Other Dressings | Dressings | 696 |
|
Olanzapine 5mg oral lyophilisates sugar free
040201060AAAEAE
|
Olanzapine | Olanzapine | Central Nervous System | 696 |
|
Pirinase Hayfever 0.05% nasal spray
1202010M0BDAAAC
|
Pirinase | Fluticasone propionate (Nasal) | Ear, Nose and Oropharynx | 696 |
|
Sharpsguard disposal unit 3.75 litre
21012600187
|
Sharpsguard disposal unit 3.75 litre | Other Appliances | Appliances | 696 |
|
UrgoStart Contact dressing 10cm x 10cm
20031600131
|
UrgoStart Contact dressing 10cm x 10cm | Wound Management & Other Dressings | Dressings | 696 |
|
Ergocalciferol 12.5microgram tablets
0906040N0AAEWEW
|
Ergocalciferol | Ergocalciferol | Nutrition and Blood | 695 |
|
Fluticasone propionate 50micrograms/dose dry powder inhaler
0302000N0AAARAR
|
Fluticasone propionate (Inhalation) | Fluticasone propionate (Inhalation) | Respiratory System | 695 |
|
Inhixa 150mg/1ml solution for injection pre-filled syringes
0208010D0BCAGAG
|
Inhixa | Enoxaparin | Cardiovascular System | 695 |
|
Activon Tulle gauze dressing 10cm x 10cm
20040200431
|
Activon Tulle gauze dressing 10cm x 10cm | Gauzes & Gauze Tissue | Dressings | 694 |
|
Colecalciferol 400units/dose oral spray sugar free
0906040G0AACICI
|
Colecalciferol | Colecalciferol | Nutrition and Blood | 694 |
|
Irrigation clamp
23700707002
|
Irrigation clamp | Irrigation Washout Appliances | Stoma Appliances | 694 |
|
Meritene Energis Soup oral powder 50g sachets chicken
0913311B0BBAAAA
|
Meritene OTC or discontinued soup | Powder OTC or discontinued soup (0913311) | Nutrition and Blood | 694 |
|
NovaLife 1 soft convex ileostomy bag maxi opaque 15-44mm
23600706467
|
NovaLife 1 soft convex ileostomy bag maxi opaque 15-44mm | Ileostomy Bags | Stoma Appliances | 694 |
|
Simpla Profile sterile leg bag 350ml tube 6cm
22501005065
|
Simpla Profile sterile leg bag 350ml tube 6cm | Leg Bags | Incontinence Appliances | 694 |
|
Byetta 10micrograms/0.04ml inj 2.4ml pre-filled pens
0601023Y0BBABAB
|
Byetta | Exenatide | Endocrine System | 693 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.